Aarti Pharmalabs MD, chairman, board of directors and AGM

Mutual fund votes, meeting of 22 Sep 2026, 1 fund house so far (houses' deadline to file 15 Oct 2026)

• To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and Auditors’ thereonMoreLess

  1 for0 against
• To declare a final dividend of ₹ 2/- (Rupees Two only) per Equity Share of Face Value of ₹ 5/- each for the financial year ended March 31, 2026

  1 for0 against
• Shri Rajendra Gogri (DIN: 00061003), Director liable to retire by rotation at this 7th Annual General Meeting, who has not offered himself for re-appointment upon expiry of his term, be not re-appointed as a Director of the Company and the vacancy, so created on the Board of Directors of the Company, be not filled.MoreLess

  1 for0 against
• To ratify remuneration payable to the Cost Auditors of the Company for the financial year ending March 31, 2027.

  1 for0 against
• To approve change in designation of Smt. Hetal Gogri Gala (DIN: 00005499) from Managing Director to Whole-time Director of the Company with effect from October 1, 2026.

  ›Against Angel One Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Company’s remuneration practice has been skewed in favour of proposed appointee and no rationale / justification has been provided by the Company regarding such disproportionate remuneration payment. Further, the Company has not provided absolute cap on the proposed variable pay / commission or the total remuneration payable to the proposed appointee.

  0 for1 against
• Appointment of Shri. Rashesh C. Gogri (DIN:00066291) as the Managing Director pursuant to change in his designation from Non-Executive Director to Managing Director of the Company with effect from October 1, 2026MoreLess

  ›Against Angel One Mutual Fund

  • Angel One Mutual FundGovernance Concern: Excessive time commitment - Holds / continue to hold two full-time positions in entities which although operating in similar line of business, but do not hold any stake in each-other. Governance and Transparency Concern: The Company’s remuneration practice has been skewed in favour of Promoter Executive Director and no rationale / justification has been provided by the Company; and the appointed is Chairman related to Managing Director/Executive Director and also Nomination & Remuneration Committee Member, hence, failed in his duties to bring fair remuneration practice. Further, the Company has not provided absolute cap on the proposed variable pay / commission or the total remuneration payable to the proposed appointee.

  0 for1 against

Mutual fund votes, meeting of 22 Sep 2025, 8 fund houses

• To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and Auditors’ thereon.MoreLess

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund

  • Angel One Mutual FundThe Company has not disclosed financial statements of any of its subsidiaries for FY 2024-25 on its website.
  • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundUnqualified financial statements (except certain non-material remarks identified in CARO report). Compliant with Indian Accounting Standards. Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: The Company has not disclosed financial statements of any of its subsidiaries for FY 2024-25 on its website.

  4 for4 against
• To declare the final dividend on Equity Shares for the financial year 2024-25

  8 for0 against
• To appoint a Director in place of Shri Parimal H. Desai (DIN: 00009272), who retires by rotation and being eligible, offers himself for re-appointment.

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund

  • Angel One Mutual Fund"The director’s re-appointment beyond 75 years of age is being proposed through an ordinary resolution, instead of the special resolution and no specific justification for continuation beyond 75 years of age; Transparency Concern: Lack of clarity regarding the total number of full-time positions held by the Director."
  • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concerns on the merits of the Director. Non-Compliance under SEBI (LODR) Regulations: The director’s re-appointment beyond 75 years of age is being proposed through an ordinary resolution, instead of the special resolution and no specific justification for continuation beyond 75 years of age; Transparency Concern: Lack of clarity regarding the total number of full-time positions held by the Director.

  4 for4 against
• Re-appointment of Smt. Rupal Vora (DIN: 07096253) as an Independent Director of the Company for a second term of 3 years

  8 for0 against
• Ratification of remuneration payable to the Cost Auditors of the Company for the Financial Year 2025-26

  8 for0 against
• Appointment of Secretarial Auditor of the Company for a term of five consecutive years from the Financial Year 2025-26

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund

  • Angel One Mutual FundAudit fee paid to outgoing auditors not disclosed; material change in audit fee cannot be ascertained.
  • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundAppointment Compliant with law. Transparency Concern: Previous Auditor’s remuneration has not been disclosed, therefore, Material Change, if any, in the Audit Fee proposed vs outgoing auditor’s audit fee cannot be ascertained.

  4 for4 against
• Approval for revision in terms of Managerial Remuneration of Shri Narendra Jagannath Salvi (DIN: 00299202), Managing Director of the Company

  8 for0 against
• Approval to extend the benefits and grant of options to the employee(s) of subsidiary company(ies) under the Aarti Pharma Performance Stock Option Plan 2023 (‘PSOP 2023’)

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Unifi Mutual Fund

  • Angel One Mutual FundInadequate disclosure of exercise price.
  • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundOriginal Scheme Non-Compliant with SEBI (SBEB & SE) Regulations, 2021: Exercise Price not disclosed, left to be determined as per Board/NRC discretion.
  • HDFC Mutual FundWe do not support ESOP schemes that are issued at a significant discount to market price. We do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
  • Unifi Mutual FundAt the 2023 AGM, the company had sought shareholder approval for the Aarti Pharma Performance Stock Option Plan 2023 (PSOP 2023), under which up to 700,000 performance stock options could be granted. The company now seeks shareholder approval to extend the scheme to its subsidiary companies. Stock options under PSOP 2023 were granted at the face value of Rs. 5.0 per share, which is at a significant discount to market price. We do not support ESOP schemes that are issued at a significant discount to the prevailing market price, unless vesting is strictly linked to disclosed performance parameters and the targets have been disclosed. In this case, the company has not provided clarity on the vesting conditions or performance metrics. Therefore, we do not support the scheme and extension of the scheme to subsidiaries.

  1 for7 against

The board is made up as the listing rules require

Yes

The board has a regular chairperson

Yes

The company has a risk management committee

Yes

The chair is related to the managing director

Yes

The filing has a part on fines and penalties

No

The filing has a part on tax disputes

No

There was a cyber security incident in the quarter

No

The company's own answers in its filing.